PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsAbrineurin
Abrineurin
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
137 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
DepressionD003863—F33.9——111618
SchizophreniaD012559EFO_0000692F20——11810
Bipolar disorderD001714EFO_0000289F30.9——1124
Metabolic syndromeD024821EFO_0000195E88.810———112
Obsessive-compulsive disorderD009771EFO_0004242F42———112
Compulsive personality disorderD003193—F60.5———112
PhenylketonuriasD010661—E70.0———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Depressive disorderD003866EFO_1002014F32.A——1—1011
Major depressive disorderD003865EFO_0003761F22——1—78
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PainD010146EFO_0003843R52—1——23
Knee osteoarthritisD020370EFO_0004616M17—1——12
OsteoarthritisD010003EFO_0002506M15-M19—1——12
Huntington diseaseD006816Orphanet_399G10—1——12
ArthritisD001168EFO_0005856M05-M14—1——12
Hearing lossD034381EFO_0004238H91.911———1
Sensorineural hearing lossD006319—H90.511———1
DeafnessD003638EFO_0001063H91.911———1
Nerve compression syndromesD009408——11———1
Charcot-marie-tooth diseaseD002607EFO_0004148G60.011———1
Show 4 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cognitive dysfunctionD060825—G31.841———1314
StrokeD020521EFO_0000712I63.91———67
Healthy volunteers/patients———1———45
Alzheimer diseaseD000544EFO_0000249F031———34
Prostatic hyperplasiaD011470EFO_0000284N401————1
Mood disordersD019964EFO_0004247F30-F391————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Motor activityD009043EFO_0003940—————77
Traumatic brain injuriesD000070642—S06————55
Brain injuriesD001930—S06.9————55
Ischemic strokeD000083242——————44
Chronic painD059350——————44
ObesityD009765EFO_0001073E66.9————33
InflammationD007249MP_0001845—————33
SyndromeD013577——————33
Mental disordersD001523EFO_0000677F91.9————33
Multiple sclerosisD009103EFO_0003885G35————33
Show 100 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameAbrineurin
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use